We examined cognitive predictors of speech and articulation rate in 50 individuals with multiple sclerosis (MS) and 23 healthy controls. We measured speech and articulation rate from audio-recordings of participants reading aloud and talking extemporaneously on a topic of their choice (i.e., self-generated speech). Articulation rate was calculated for each speech sample by removing lexically irrelevant vocalizations and pauses of \u3e200 ms. Speech rate was similarly calculated including pauses. Concurrently, the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery, as well as standardized tests of sentence intelligibility and syllable repetition were administered. Analysis of variance showed that MS patients wer...
Objective:Executive functioning (EF) can be one of the earliest, despite under-detected, impaired co...
Our research studied relapsing-remitting multiple sclerosis (RRMS). In half of the RRMS cases, mild...
There is a need for reliable and objective measures of early and mild symptomology in multiple scler...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
This preliminary study investigated how cognitive-linguistic status in multiple sclerosis (MS) is re...
Objective: To investigate the impact of cognitive impairment on spoken language produced by speakers...
Objective: To investigate the impact of cognitive impairment on spoken language produced by speakers...
A quantitative review of 35 studies with 3673 participants was conducted to estimate and compare the...
Purpose: Dysarthria is a consequence of multiple sclerosis (MS) that can co-occur with cognitive imp...
Background: Cognitive-linguistic deficits are a concern in multiple sclerosis (MS). Thus, clinical m...
Multiple sclerosis (MS) is a disabling neurological disease with varied symptoms, including dysarthr...
International audienceIntroduction: Cognitive impairment is frequent in persons with multiple sclero...
Objective:Executive functioning (EF) can be one of the earliest, despite under-detected, impaired co...
Our research studied relapsing-remitting multiple sclerosis (RRMS). In half of the RRMS cases, mild...
There is a need for reliable and objective measures of early and mild symptomology in multiple scler...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
International audienceCognitive impairment (CI) affects 40–65% of patients with multiple sclerosis (...
This preliminary study investigated how cognitive-linguistic status in multiple sclerosis (MS) is re...
Objective: To investigate the impact of cognitive impairment on spoken language produced by speakers...
Objective: To investigate the impact of cognitive impairment on spoken language produced by speakers...
A quantitative review of 35 studies with 3673 participants was conducted to estimate and compare the...
Purpose: Dysarthria is a consequence of multiple sclerosis (MS) that can co-occur with cognitive imp...
Background: Cognitive-linguistic deficits are a concern in multiple sclerosis (MS). Thus, clinical m...
Multiple sclerosis (MS) is a disabling neurological disease with varied symptoms, including dysarthr...
International audienceIntroduction: Cognitive impairment is frequent in persons with multiple sclero...
Objective:Executive functioning (EF) can be one of the earliest, despite under-detected, impaired co...
Our research studied relapsing-remitting multiple sclerosis (RRMS). In half of the RRMS cases, mild...
There is a need for reliable and objective measures of early and mild symptomology in multiple scler...